A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences. [electronic resource]
Producer: 20040917Description: 204-10 p. digitalISSN:- 1075-122X
- Actuarial Analysis
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Radiation-Sensitizing Agents -- administration & dosage
- Radiotherapy, Adjuvant
- Survival Analysis
- Thoracic Wall -- pathology
- Time Factors
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.